PerkinElmer appoints director of lab operations for genetic screening business

PerkinElmer has appointed John E Sherwin as its new director of laboratory operations for its screening business.

In his new role, Mr Sherwin will be responsible for overseeing and directing the growth of PerkinElmer’s genetic screening laboratory services offerings, including PerkinElmer Genetics, a neonatal screening laboratory and NTD Laboratories which specialises in prenatal risk assessment.

Prior to joining PerkinElmer, Mr Sherwin served as acting chief of the Genetic Disease Branch – responsible for the prenatal and newborn screening programme in California.

Speaking of the appointment, Anne-Christine Sundell, president of genetic screening at PerkinElmer, said: "We are fortunate to have someone with John’s experience join our team as we continue to expand our world-class neonatal and prenatal/maternal health solutions and services portfolio to help protect the health of mothers and babies around the world from pregnancy to birth and beyond."

In related news, PerkinElmer has opened a new Centre of Excellence in Singapore.

The centre will focus upon developing new precision instruments and chemistries for a variety of scientific and industrial laboratory applications, including drug discovery and development, environmental monitoring, food safety, and sustainable energy.